IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA. FMHR [Internet]. 2025 Dec. 18 [cited 2026 Nov. 10];3(10):570-7. Available from: https://fmhr.net/index.php/fmhr/article/view/1765